secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K/A
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001606498-23-000018
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical estimates $20M-$25M cash costs for transformation; expects $45M-$55M gross savings by 2025
--------------------------------------------------------------------------------

- Cash expenses of $20M-$25M for transformation: $9M-$12M consulting/retention, $8M-$11M manufacturing/supply chain.
- Employee severance and benefits costs estimated at $6M-$8M.
- Anticipated savings of ~$10M in 2023; gross savings of $45M-$55M by 2025, mostly in 2024.
- Plan includes combining Chronic Care and Pain franchises, exiting low-margin products, and cost management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000018/0001606498-23-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000018/avns-20230110.htm
  HTML page:      https://secwatch.observer/filing/0001606498-23-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer